Navigation Links
Nanomedicine Gives the Way for Nerve Cell Regeneration

researchers describe the use of nanotechnology to enhance the regeneration of nerve cells. In the first method, developed at the University of Miami , researchers show how magnetic nanoparticles (MNPs) may be used to create mechanical tension that stimulates the growth and elongation of axons of the central nervous system neurons.

The second method from the University of California, Berkeley uses aligned nanofibers containing one or more growth factors to provide a bioactive matrix where nerve cells can regrow.

It is known that injured neurons in the central nervous system (CNS) do not regenerate, but it is not clear why. Adult CNS neurons may lack an intrinsic capacity for rapid regeneration, and CNS glia create an inhibitory environment for growth after injury. Can these challenges be overcome even before we fully understand them at a molecular level "why axons in central nervous system do not regenerate"" Dr. Mauris N. De Silva describes the novel nanotechnology based approach designed that includes the use of magnetic nanoparticles and magnetic fields for addressing the challenges associated with regeneration of central nervous system after injury.

"By providing mechanical tension to the regrowing axon, we may be able to enhance the regenerative axon growth in vivo". This mechanically induced neurite outgrowth may provide a possible method for bypassing the inhibitory interface and the tissue beyond a CNS related injury. Using optic nerve and spinal cord tissues as in vivo models and dissociated retinal ganglion neurons as an in vitro model, De Silva and his colleagues are currently investigating how these magnetic nanoparticles can be incorporated into neurons and axons at the site of injury.

Although, this study is at a very preliminary stage to explore the possibility of using magnetic nanoparticles for enhancing in vivo axon regeneration, this work may have significant implications for the treatment of
'"/>




Page: 1 2 3 4

Related medicine news :

1. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
2. Gene Therapy Gives Hope For Patients With Muscular Dystrophy
3. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
4. US Doctors Association Gives away $110,000 To NGO’
5. Woman In Coma Gives Birth To Daughter
6. Artificial Heart , Gives Hope For Patients Awaiting a Heart Transplant
7. New Eye Surgery Gives Hope To Short-Sighted
8. Jharkhand Gives Health industry status
9. WHO Gives Its Approval For Bird Flu Test Kit
10. FDA Gives Its Approval For Inhaler
11. Congestion for Use of Clarinex-D 12 Hour cleared – FDA Gives the No
Post Your Comments:
(Date:7/8/2008)...following statement was issued,today by the law fi...otice is hereby given that a class action lawsuit ...the Middle District of Tennessee on behalf,of all ...q: HWAY ),("Healthways" or the "Company") from Oc...e (the "Class Period")., If you wish to discuss t...
(Date:7/8/2008)...elays in Oxygen Orders, Lack of,Trained Technician... -- The new Medicare,competitive bidding program f...nd chaos for beneficiaries, physicians, hospital d...viders across the country since it,was implemented... program has triggered widespread disruptions in s...
(Date:7/8/2008)...ociety of Hematology (ASH) is proud to announce th... Pathway Grant. The grant is given to training pro...plementation of novel hematology-related training ...sity, Donald Mahoney Jr., MD, of Baylor College of...Sinai School of Medicine, will each receive the gr...
(Date:7/8/2008)...os Innovation,s Proprietary,Device-Free Remote Mo... and Medical Costs, N...ovations, a pioneer,in assisting clients to achiev...ce improvement through a device-free remote monito...e Iowa Medicaid Congestive Heart Failure,Populatio...
Breaking Medicine News(10 mins):Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 2Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3
...by Japanese government and produced by Unicef, the... Food and Agriculture// Organization, features Jac...untries and some colorful origami birds urging chi...In the advertisement shot in English at Sha Tin Ju...
...Britain and promoted by pop star Beyonce Knowles, ...ays.// All over the country, health shops are se...he shelves after pop star Beyonce Knowles said she... her latest film. The syrup, is said to be made ...
...desh to help malnourished children is yet to make ...led to aid the 5.7 million malnourished children o... age, Grassroots Features reported. Two-and-a-hal...riya tribal couple's daughter from Amolpath villag...
...iversity published his findings on a better substi...his month//. According to peer-reviewed research p...the kind of immune response doctors were looking f...ing, the vaccine was given to 100 volunteers at fo...
Other Medicine News:Health News:Scheme for Combating Malnourishment in MP Children Yet to Pick Up 2
(Date:7/7/2008)...- Light Sciences Oncology, Inc.,(LSO) today announ...enign,prostatic hyperplasia (BPH), or enlargement ...(Litx(TM)), an innovative light-activated drug,tre...2-patient, Phase I/II,dose-escalation study at fou...nt, Phase IIa study in Australia, expected to begi...
(Date:7/7/2008)...irstCall/ -- Biopure Corporation,(Nasdaq: BPUR ) ...he Food,and Drug Administration (FDA) on identifyi...ical trial of Hemopure(R) [hemoglobin glutamer -,2... study use of Hemopure,in patients suffering from ...usion with blood components. Currently, AML patien...
(Date:7/6/2008)...horization Application currently ...- Cell Therapeutics, Inc. (...lication of results from its,randomized phase III ...,CT-2103) with gemcitabine or vinorelbine for the ...with previously untreated non-small cell,lung canc...
(Date:7/3/2008)...sachusetts, July 3,/-, -...ny, Jerini AG for an equity purchase price of EUR...oduct, FIRAZYR(R), to its Human Genetic Therapies ...es expected to be around $350-400 million, based ...ent, - Expected to be accretive for Non GAAP earn...
Breaking Medicine Technology:Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate 2Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate 3Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 1Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 2Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 3Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 4Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 1Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 2Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 3Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 4Syngenta Licenses Chromatin Gene Stacking Technology 1373 1Syngenta Licenses Chromatin Gene Stacking Technology 1373 2Research approved for Hawaiian military training area 888 1Research approved for Hawaiian military training area 888 2
...nt Plans - , ,OTTAWA, Canada – March 7, 2007...al company specializing in developing,advanced pro...ften,called “good cholesterol,” today ... of its lead product, CRD5. CRD5 is,being develope...ase. , ,Results showed, to date, that CRD5 was saf...
... 12, 2007 - Ceragenix Pharmaceuticals,Inc. (OTCBB...ectious disease and dermatology, today announced t...emonstrated virtually no biofilm,formation in a 21...treated with Ceragenins,were soaked daily in a pho...atheter. At day 21, the catheters were challenged ...
Other Medicine Technology:Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 2Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 3Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: